Table 1

Covariates	3 months good EULAR response			6-12 months LDA/remission

	RR	CI 95%	p value	HR	CI 95%	p value

Age	0.98	0.94–1.01	0,31	1.01	0.94–1.08	0.72
Sex (female/male)	1.44	0.32–6.35	0.62	0.16	0.18–1.43	0.10
Disease duration	1.02	0.60–1.74	0.92	0.98	0.89–1.07	0.68
Baseline DAS28	1.63	0.95–2.79	0.07	1.20	0.64–2.28	0.55
Good EULAR at 3 months	_	_	_	11.3	13.1–34.8	0.0001
DMARDs co-therapy (no/yes)	0.75	0.84–144	0.69	0.85	0.84–1.24	0.64
Glucocorticoids (no/yes)	0.70	0.02–1.13	0.45	0.40	0.002–1.04	0.05
Body Mass Index	1.02	0.91–1.14	0.68	0.88	0.74–1.04	0.14
1st line vs ≥2 line	6.74	1.97–23.1	0.002	4.09	0.44–37.5	0.21